Bcl-2 family proteins are important regulators of apoptosis. To clarify a role of apoptosis and the expression of Bcl-2 family proteins in the pathogenesis of subacute thyroiditis (SAT), we evaluated the expression of Bcl-2, Bax, and Bak by immunohistochemistry and apoptosis by in situ end labeling of fragmented DNA in thyroid tissues from 11 patients with SAT. Apoptotic nuclei were found in granulomas, especially in macrophages/histiocytes and lymphocytes, and in the regenerating follicular cells, but were rarely found in the area of fibrosis. The mean (ϮSD) percentage of apoptotic follicular cells was significantly greater in SAT than that in controls (1.4 Ϯ 0.8% vs. 0.4 Ϯ 0.6%). Bcl-2, Bak, and Bax were strongly expressed in the granulomas and regenerating thyroid follicular cells from patients with SAT. Bcl-2 and Bak, but not Bax, were expressed in follicular cells from normal controls. The percentage of apoptotic cells and the expression of Bax in follicular cells did not correlate with age or serum levels of thyroid hormones, C-reactive protein, or thyroglobulin. These data suggest that apoptosis may be involved in the development of SAT and that Bax expression in regenerating thyrocytes may be important for the recovery of SAT. (J Clin Endocrinol Metab 84: 2221-2225, 1999 S UBACUTE thyroiditis (SAT) is a transient destructive thyroiditis, characterized by painful toxic goiter with systemic inflammation (1). Most patients with SAT recover within several months, but about 10 -20% of patients treated with glucocorticoids have recurrences (2). From pathological examination, various stages of the disease are sometimes found within the same specimen. Initially, there is extensive follicular cell destruction, extravasation of colloid, and infiltration of lymphocytes and histiocytes. The latter tend to congregate around masses of colloid and coalesce into giant cells. With time, there is a variable degree of fibrosis, and areas of follicular regeneration are seen. After recovery, the thyroid appears normal, except for minimal residual fibrosis. Although it has been reported that SAT may be associated with viral infection, the etiology of the disease and the mechanisms of the destruction and regeneration of thyroid follicles have not been fully elucidated.
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Apoptosis is a type of cell death and has been demonstrated to contribute to cell destruction in a number of diseases. Important regulators of apoptosis are the Fas/Fas ligand system (3), proteins encoded by bcl-2 family genes (4), tumor necrosis factor receptor, and caspases (5) . Fas/Fas ligand interaction and apoptosis have been demonstrated to contribute to the pathogenesis of Hashimoto's thyroiditis (6, 7) , although Fas ligand expression in thyrocytes is controversial (8 -10) . The ratio of the expression of death antagonists (Bcl-2, Bcl-XL, and Mcl-1) to death agonists (Bax, Bak, Bcl-Xs, and Bad) determines the survival or death of cells in physiological and pathological conditions such as cancer growth (4, 11, 12) and neuronal apoptosis after cerebral artery occlusion (14) . However, there is no report on the expression of Bcl-2 family proteins in SAT.
The aim of the present study was to determine the presence of apoptosis and the expression of Bcl-2, Bax, and Bak at various stages in thyroid tissues from patients with SAT.
Materials and Methods

Thyroid tissue
We obtained thyroid specimens from 11 patients with SAT (all women; aged 39 -61 yr; mean age, 50 Ϯ 8 yr), 2 of whom were associated with thyroid tumor. The diagnosis of SAT was based on painful goiter with systemic inflammatory signs and lack of 131 I thyroid uptake in the hyperthyroid state. At the time of biopsy, 8 patients were euthyroid, 2 were hyperthyroid, and the remaining patient was hypothyroid. Four patients had been treated with glucocorticoid (Table 1 ). Serum C reactive protein was positive at the time of biopsy in 7 patients. Normal thyroid tissue was obtained from 6 patients with thyroid cancer or adenoma, all women, aged 17-62 yr (mean, 44 Ϯ 21 yr), as a control. The study protocol was approved by the institutional review board of Koike Hospital, and informed consent was obtained from all subjects after explanation of the study.
Detection of apoptosis
Apoptotic cells were detected by in situ end labeling of fragmented DNA using assay kits (Apop Tag, in situ apoptosis detection kit, peroxidase, Oncor Inc., Gaithersburg, MD) as previously described (15) . The paraffin-embedded tissue sections were deparaffinized by xylene and ethanol. Sections were then treated with proteinase K (20 g/mL) for digesting protein in tissue. Digoxigenin-deoxy-UTP was added to the 3Ј-OH ends of DNA by terminated deoxynucleotidyl transferase. After incubating with anti-digoxigenin antibody conjugated with peroxidase, the sections were stained with diaminobenzidine and counterstained with methyl green. The mean percentage of positive staining of nuclei was calculated after counting positively or negatively staining nuclei of 500 thyrocytes in several fields under light microscope by 2 observers.
Immunohistochemistry
Immunohistochemical staining was performed using mouse monoclonal antibodies against human Bcl-2 (IgG1; DAKO Corp. A/S, Glostrup, Denmark) and Bak (IgG2a; Oncogene Science, Inc., Cambridge, MA), rabbit polyclonal antibody against Bax (IgG; Oncogene Science, Inc.), and mouse IgG1 (DAKO Corp.), mouse IgG2a (DAKO Corp.), and normal rabbit Ig (DAKO Corp.) as negative controls. Positive reactivity was identified using a streptavidin-biotin-peroxidase detection system (DAKO Corp. catalyzed signal amplification system, DAKO Corp.) as previously reported (15) . Briefly, the paraffin-embedded tissue sections were deparaffinized, then put in Target Retrieval Solution (DAKO Corp.) to amplify the signal, placed in a water bath (95-97 C) for 20 -40 min, and then cooled for 20 min at room temperature. After blocking endogenous peroxidase activity with a 3% hydrogen peroxidase solution for 10 min, intrinsic biotin with an endogenous avidin/ biotin blocking kit (Nichirei Corp., Tokyo Japan), and nonspecific binding by serum-free protein, the tissue was incubated with prediluted mouse monoclonal antibodies (10 g/mL) or rabbit polyclonal antibodies (5 g/mL) for 15 min, followed by 15-min incubation with a biotinylated rabbit antimouse IgGϩMϩA antibody or goat antirabbit IgG antibody and 15-min incubation with streptavidin-biotin-peroxidase complex, biotinyl tyramide, hydrogen peroxide, and streptavidin conjugated with peroxidase. Staining was completed with diaminobenzidine for 5 min, and the specimens were counterstained with Mayer's hematoxylin for 2-5 min.
To detect the cell types that undergo apoptosis in the inflamed tissue, we performed a double immunostaining as follows. After apoptotic signal was identified as described above, a cell type-specific antibody for CD45 (DAKO Corp.), CD68 (DAKO Corp.), or vimentin (DAKO Corp.) was stained using alkaline phosphatase-conjugated streptavidin (Nichirei Corp.) and visualized with a fast blue substrate kit (Nichirei Corp.), as described previously (16) .
Statistical analysis
Differences in the expression of Bcl-2 family proteins and percentages of apoptotic cells between groups were evaluated using Mann-Whitney U test or Fisher's exact probability test. Correlation was assessed by Spearman's signed ranks test. P Ͻ 0.05 was considered significant.
Results
Apoptotic cells in thyroid tissues
Apoptotic nuclei were observed in the area of granuloma (Fig. 1A) . Most cell types undergoing apoptosis in the inflamed tissues were macrophages/histiocytes (Fig. 1B) and lymphocytes, but not multinucleate giant cells. Apoptotic nuclei were also found in regenerating follicular cells, which took place as a group in an insular pattern in the fibrous stroma and showed hypertropic cytoplasms and enlarged nuclei with prominent nucleoli (Fig. 1D) . Apoptotic nuclei were rarely found in the area of fibrosis, where many collagen fibers were dominant (Fig. 1C) . In normal thyroid glands, apoptotic nuclei were occasionally found in follicular cells (Fig. 1E) . The mean (Ϯsd) percentage of apoptotic follicular cells was significantly greater in SAT than that in controls (1.4 Ϯ 0.8% in SAT and 0.4 Ϯ 0.6% in normal controls; by Mann-Whitney U test, P Ͻ 0.05). 
Expression of Bcl-2, Bax, and Bak in thyroid tissues
Bcl-2 (Fig. 2, A-C) , Bax (Fig. 2 , E-G), and Bak (Fig. 2, I -K) were expressed in the area of granuloma (Fig. 2, A , E, and I) and regenerating thyroid follicular cells (Fig. 2, B , F, and J), but not in the area of fibrosis (Fig. 2, C, G, and K) , from all patients with SAT. Although Bcl-2 and Bak were expressed in normal follicular cells from the six control tissues examined (Fig. 2, D and M) , Bax was not expressed in follicular cells from the six control tissues examined (Fig. 2H) .
Relation of apoptosis and Bcl-2 family protein expression in thyroid to the clinical parameters of SAT
Bax expression was weaker in four patients with SAT, and three of them had been treated with glucocorticoids ( Table  1 ). The percentages of apoptotic follicular cells in patients with SAT were not significantly correlated with the expression of Bcl-2, Bax, or Bak; age; serum thyroid hormones; C-reative protein; or thyroglobulin levels.
Discussion
We have characterized, for the first time, the presence of apoptosis and the expression of Bcl-2 family proteins, namely Bcl-2, Bax, and Bak, in thyroid tissue from patients with SAT. In summary, 1) apoptosis was observed in the area of granuloma. Apoptotic cells were mainly macrophages/histiocytes and lymphocytes in the granuloma. 2) Apoptotic cells were also found in regenerating follicular cells, but only rarely in the area of fibrosis in SAT. The percentages of apoptotic nuclei of thyroid follicular cells in SAT were significantly greater than those in control subjects. 3) Bax, an apoptosis agonist, was expressed in the area of granuloma and regenerating follicular cells in all patients with SAT, but was not expressed in normal thyroid follicular cells from control subjects. 4) Although Bcl-2 and Bak were also expressed in the area of granuloma and regenerating follicular cells in SAT, they were constitutively expressed in normal thyroid follicular cells.
Although the close association with human leukocyte an- tigen Bw35 supports the role of cytotoxic T cell immunity in SAT (2), the precise mechanism of the thyroid cell destruction is unclear. The present demonstration of apoptotic nuclei in the area of granuloma suggests the involvement of apoptosis in the development of SAT. Apoptosis was rarely seen in sites of fibrosis, which might be a healing process. The increased levels of apoptosis in the regenerating follicular cells may be related to shorter turnover of regenerating follicular cells compared with that of well differentiated normal thyroid follicular cells. This may represent a physiological feature of regenerating follicular cells.
It is now known that the bcl-2 gene family regulates apoptosis (4). The present study confirmed that normal thyroid follicular cells expressed Bcl-2 and Bak, but not Bax (12, 17, 18) , suggesting that Bcl-2 and Bak expression in differentiated normal thyroid follicular cells might regulate apoptosis in the physiological state. In contrast, in the area of granulomatous changes in SAT, Bax expression was detected in follicular cells and inflammatory cells. These data suggest that the increased expression of Bax may contribute to the apoptosis in the lesion.
Furthermore, we demonstrated the expression of Bax in the regenerating follicular cells for the first time. Basile et al. (19) reported the up-regulated expression of Bax in regenerating proximal tubules after ischemic injury. The up-regulation of Bax gene expression and Bax expression have also been reported in rat (20) and mice (21) liver regeneration after partial hepatectomy and in muscle regeneration in muscular dystrophies (22) . Those reports support that Bax expression in regenerating thyroid follicular cells may play an important role in the recovery of SAT.
In conclusion, results from the present study suggest the involvement of apoptosis in the development of SAT in its various stages. Furthermore, Bax expression in the regenerating follicular cells may play a role in the recovery of SAT. As the number of patients studied was small, two patients were associated with thyroid cancer, and four patients had been treated with glucocorticoids, which might down-regulate Bax expression (23) , further studies are indicated to clarify the precise role of Bcl-2 family proteins in thyroid cell damage and recovery in SAT and their implications with respect to its therapy. 
